Cognition Therapeutics sued by former CEO for $4M


Complaint alleges Pittsburgh-founded biopharm company cost exec millions due to how it handled his stock options.

Previous How an expected recession could affect Atlanta, says Wells Fargo economist
Next Bank of Texas promotes Dallas-based executive to CEO role